摘要
目的分析3.0TMR动态增强曲线联合ADC用于乳腺良恶性病变鉴别诊断中的效果。方法选取2020年7月-2022年7月我院收治的78例乳腺病变患者,依据病理诊断结果将患者分为良性病变组(35例)和恶性病变组(43例),所有患者均接受3.0TMR动态增强曲线、ADC检查,以病理检查结果为标准,分析3.0TMR动态增强曲线、ADC单独诊断的准确率以及3.0TMR动态增强曲线联合ADC诊断的检出率。结果本次研究结果显示,良性病变组患者的动态增强曲线结果与恶性病变组患者相比差异显著(P<0.05),恶性病变组患者ADC值为(6.24±1.42)%,良性病变组患者ADC值为(12.63±2.25)%,恶性病变组患者ADC值与良性病变组相比明显更低(P<0.05);与3.0TMR动态增强曲线、ADC单独诊断相比,3.0TMR动态增强曲线联合ADC诊断的的特异度和敏感度均明显更高(P<0.05)。结论3.0TMR动态增强曲线联合ADC用于乳腺良恶性病变鉴别诊断中具有良好的效果,能够获得较高的特异度、敏感度,值得在临床推广。
Objective to analyze the efficacy of 3.0 TMR dynamic enhancement curve combined with ADC in the differential diagnosis of benign and malignant lesions of the breast.Methods a total of 78 patients with breast lesions treated in our hospital from July 2020 to July 2022 were selected,and the patients were divided into benign lesion group(35 patients)and malignant lesion group(43 patients)based on pathological diagnosis results,All patients underwent 3.0tmr dynamic enhancement curve,ADC examination,and pathological findings were used as the standard,The 3.0tmr dynamic enhancement curve was analyzed to evaluate the accuracy of ADC diagnosis alone and the detection rate of 3.0tmr dynamic enhancement curve combined with ADC diagnosis.Results the results of this study showed that the dynamic enhancement curve results of patients in the benign lesion group were significantly different from those of patients in the malignant lesion group(P<0.05),the ADC value of patients in the malignant lesion group was(6.24±1.42)%,the ADC value of patients in the benign lesion group was(12.63±2.25)%,and the ADC value of patients in the malignant lesion group was significantly lower compared with that of patients in the benign lesion group(P<0.05);Compared with 3.0tmr dynamic contrast-enhanced curve,ADC alone had significantly higher specificity and sensitivity than ADC diagnosis combined with 3.0tmr dynamic contrast-enhanced curve(P<0.05).Conclusion the 3.0tmr dynamic enhancement curve combined with ADC has a good effect in the differential diagnosis of benign and malignant breast lesions,is able to achieve high specificity,sensitivity,and is worth promoting in the clinic.
作者
段斌
王啸江
孔玲
DUAN Bin;WANG Xiao-jiang;KONG Ling(Xuchang Central Hospital Affiliated to Henan University of Science and Technology,Department of medical imaging,Xuchang 461000,Henan Province,China)
出处
《罕少疾病杂志》
2023年第8期51-52,共2页
Journal of Rare and Uncommon Diseases
基金
河南省医学科技攻关计划(LHGJ20191398)。